White and grey matter abnormalities in patients with SPG11 mutations
- PMID: 22696581
- DOI: 10.1136/jnnp-2011-300129
White and grey matter abnormalities in patients with SPG11 mutations
Abstract
Background: Mutations in SPG11 are the most frequent known cause of autosomal recessive hereditary spastic paraplegia. Corpus callosum thinning is a hallmark of the condition but little is known about damage to other structures in the CNS.
Objective: To evaluate in vivo cerebral damage in patients with SPG11 mutations.
Methods: 5 patients and 15 age and sex matched healthy controls underwent high resolution diffusion tensor imaging (32 directions) and a T1 volumetric (1 mm slices) acquisition protocol in a 3 T scanner (Philips Achieva). These sequences were then analysed through voxel based morphometry (VBM) and tract based spatial statistics (TBSS).
Results: Mean age of the patients was 23.6±4.5 years (range 14-45) and mean duration of disease was 12 years (range 5-15). All patients presented with progressive spastic paraplegia and three were already wheelchair bound when first evaluated. Mutations found were: c.529_533delATATT, c.704_705delAT, c.733_734delAT, c.118C>T and c.7256A>G. VBM identified significant grey matter atrophy in both the thalamus and lentiform nuclei. TBSS analyses revealed reduced fractional anisotropy involving symmetrically subcortical white matter of the temporal and frontal lobes, the cingulated gyrus, cuneus, striatum, corpus callosum and brainstem.
Conclusions: Widespread white matter damage in patients with SPG11 mutations has been demonstrated. Grey matter atrophy was prominent in both the thalamus and basal ganglia but not in the cerebral cortex. These findings suggest that neuronal damage/dysfunction is more widespread than previously recognised in this condition.
Similar articles
-
SPG11 mutations cause widespread white matter and basal ganglia abnormalities, but restricted cortical damage.Neuroimage Clin. 2018 Jun 9;19:848-857. doi: 10.1016/j.nicl.2018.05.031. eCollection 2018. Neuroimage Clin. 2018. PMID: 29946510 Free PMC article.
-
Diffusion tensor imaging in SPG11- and SPG4-linked hereditary spastic paraplegia.Int J Neurosci. 2014 Apr;124(4):261-70. doi: 10.3109/00207454.2013.836705. Epub 2013 Sep 27. Int J Neurosci. 2014. PMID: 23968121
-
Novel SPG11 mutations in Chinese families with hereditary spastic paraplegia with thin corpus callosum.Parkinsonism Relat Disord. 2013 Mar;19(3):367-70. doi: 10.1016/j.parkreldis.2012.10.007. Epub 2012 Oct 31. Parkinsonism Relat Disord. 2013. PMID: 23121729
-
Tract-based spatial statistics of diffusion tensor imaging in hereditary spastic paraplegia with thin corpus callosum reveals widespread white matter changes.Diagn Interv Radiol. 2013 May-Jun;19(3):181-6. doi: 10.5152/dir.2013.046. Diagn Interv Radiol. 2013. PMID: 23302284
-
Hereditary spastic paraplegia type 11: Clinicogenetic lessons from 339 patients.J Clin Neurosci. 2021 Mar;85:67-71. doi: 10.1016/j.jocn.2020.11.036. Epub 2021 Jan 15. J Clin Neurosci. 2021. PMID: 33581793
Cited by
-
Multimodal MRI-based study in patients with SPG4 mutations.PLoS One. 2015 Feb 6;10(2):e0117666. doi: 10.1371/journal.pone.0117666. eCollection 2015. PLoS One. 2015. PMID: 25658484 Free PMC article.
-
Metabolite profile in hereditary spastic paraplegia analyzed using magnetic resonance spectroscopy: a cross-sectional analysis in a longitudinal study.Front Neurosci. 2024 Aug 13;18:1416093. doi: 10.3389/fnins.2024.1416093. eCollection 2024. Front Neurosci. 2024. PMID: 39193522 Free PMC article.
-
ARL6IP1 gene delivery reduces neuroinflammation and neurodegenerative pathology in hereditary spastic paraplegia model.J Exp Med. 2024 Jan 1;221(1):e20230367. doi: 10.1084/jem.20230367. Epub 2023 Nov 7. J Exp Med. 2024. PMID: 37934410 Free PMC article.
-
Neuropsychology and MRI correlates of neurodegeneration in SPG11 hereditary spastic paraplegia.Orphanet J Rare Dis. 2022 Jul 29;17(1):301. doi: 10.1186/s13023-022-02451-1. Orphanet J Rare Dis. 2022. PMID: 35906604 Free PMC article.
-
Neuroimaging in Hereditary Spastic Paraplegias: Current Use and Future Perspectives.Front Neurol. 2019 Jan 16;9:1117. doi: 10.3389/fneur.2018.01117. eCollection 2018. Front Neurol. 2019. PMID: 30713518 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources